Characteristics of Hepatitis B and D Co-infection: A Descriptive Study
Authors:
Open Access
- 8 February 2021
- journal article
- research article
- Published by Brieflands in Hepatitis Monthly
- Vol. 21 (1)
Abstract
: About 5% of cases with chronic hepatitis B virus (HBV) are co-infected with hepatitis D virus (HDV), and this co-infection possesses a high risk for hepatocellular carcinoma (HCC) and cirrhosis. We aimed to evaluate the epidemiological and histopathological characteristics and response to treatment in patients with HBV and HDV co-infection in a hepatitis clinic in Tehran, Iran. In this study, 80 patients were enrolled and evaluated for age, sex, degree of liver fibrosis, virologic status, and response rate. The incidence of co-infection of hepatitis B and D was 4.9% (80/1,631 HBV-infected cases) in our clinic. Thirty-seven (46.25%) patients had liver cirrhosis, and four (5%) patients had HCC. Besides, HDV Ribonucleic Acid (RNA) polymerase chain reaction (PCR) was positive for 31 (38.75 %) patients. Among 30 patients, 14 (46.6%) completed interferon therapy (for equal to or more than 48 weeks) and had a response with undetectable HDV RNA PCR after treatment. According to our results, for cirrhotic patients in HBV/HDV co-infection that was about 46%, it seems that the early detection of HDV antibody (Ab) plays a significant role in the prevention of progressive liver failure, and treatment with interferon can help these patients by improving the prognosis.Keywords
This publication has 17 references indexed in Scilit:
- Economic and Health Care Burdens of Hepatitis Delta: A Study of Commercially Insured Adults in the United StatesHepatology, 2019
- Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus InfectionThe Journal of Infectious Diseases, 2019
- Prevalence of hepatitis delta infections among HBs-antigen-positive inhabitants of southeastern and northwestern parts of PolandClinical and Experimental Hepatology, 2019
- Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysisGut, 2018
- Hepatitis delta virus: insights into a peculiar pathogen and novel treatment optionsNature Reviews Gastroenterology & Hepatology, 2016
- Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster DoseThe Journal of Infectious Diseases, 2016
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013The Lancet, 2015
- Hepatitis D Virus: Introduction and EpidemiologyCold Spring Harbor Perspectives in Medicine, 2015
- Hepatitis D and hepatocellular carcinomaWorld Journal of Hepatology, 2015
- Hepatitis delta virusThe Lancet, 2011